"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in Harvard Catalyst Profiles by year, and whether "Hemostatics" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 1 | 2 |
1998 | 3 | 0 | 3 |
1999 | 0 | 2 | 2 |
2000 | 1 | 2 | 3 |
2001 | 3 | 3 | 6 |
2002 | 1 | 3 | 4 |
2003 | 3 | 1 | 4 |
2004 | 2 | 0 | 2 |
2005 | 3 | 0 | 3 |
2006 | 6 | 1 | 7 |
2007 | 3 | 1 | 4 |
2008 | 7 | 1 | 8 |
2009 | 8 | 0 | 8 |
2010 | 4 | 1 | 5 |
2011 | 5 | 3 | 8 |
2012 | 4 | 1 | 5 |
2013 | 5 | 4 | 9 |
2014 | 5 | 3 | 8 |
2015 | 10 | 0 | 10 |
2016 | 3 | 3 | 6 |
2017 | 2 | 1 | 3 |
2018 | 5 | 2 | 7 |
2019 | 1 | 1 | 2 |
2020 | 6 | 1 | 7 |
2021 | 11 | 0 | 11 |
2022 | 14 | 0 | 14 |
2023 | 10 | 1 | 11 |
2024 | 3 | 0 | 3 |
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Antifibrinolytic and Adjunct Hemostatic Agents: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference. Pediatr Crit Care Med. 2024 Jul 01; 25(7 Suppl 1):e44-e52.
-
Benefits and risks of non-factor therapies: Redefining haemophilia treatment goals in the era of new technologies. Haemophilia. 2024 Apr; 30 Suppl 3:39-44.
-
Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: The Cardiovascular Health Study. Thromb Res. 2024 Mar; 235:148-154.
-
Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience. Blood Coagul Fibrinolysis. 2024 Mar 01; 35(2):49-55.
-
Tranexamic Acid for Bleeding Management in Adult Patients on Extracorporeal Membrane Oxygenation. ASAIO J. 2023 12 01; 69(12):e474-e481.
-
Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa. J Thromb Haemost. 2023 12; 21(12):3508-3510.
-
Hemostatic considerations for gender affirming care. Thromb Res. 2023 10; 230:126-132.
-
Self-expanding foam versus preperitoneal packing for exsanguinating pelvic hemorrhage. J Trauma Acute Care Surg. 2024 May 01; 96(5):727-734.
-
The role of viscoelastic hemostatic assays for postpartum hemorrhage management and bedside intrapartum care. Am J Obstet Gynecol. 2024 Mar; 230(3S):S1089-S1106.
-
Hemostatic and Immunologic Effects of Platelet Transfusions in Neonates. Clin Perinatol. 2023 12; 50(4):793-803.